Clinical Trial Update: A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma

View source ↗

Summary

This clinical trial update reports an ongoing multi-center study evaluating zanubrutinib in combination with first-line chemoimmunotherapy for patients with gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Zhengzhou University | Conditions: Follicular Lymphoma | Status: ACTIVE_NOT_RECRUITING